Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background/Aims: We investigated changes in recurrence rates and significant recurrence predictors over time after complete cure of hepatocellular carcinoma (HCC). Methods: A total of 1,491 patients with first-time diagnosis of Barcelona Clinic Liver Cancer stage A HCC, completely cured by treatment between 2007 and 2016, were recruited from two Korean tertiary institutes. Results: The mean age of the population (1,144 men and 347 women) was 58.6 years. Of the total population, 914 patients (61.3%) had liver cirrhosis. Nine-hundred and forty-one (63.1%) and 550 (36.9%) patients were treated with surgical resection and radiofrequency ablation (RFA), respectively. One-year cumulative incidences of HCC recurrence were 14.3%, 9.9%, and 5.1% from the time of treatment, 3 years after treatment, and 5 years after treatment, respectively. Upon multivariate analysis, multiple tumors, maximal tumor size ≥3 cm, and high Model for End- Stage Liver Disease scores were independently associated with increased HCC recurrence risk from the time of treatment and 1 and 2 years after curative treatment (all p<0.05, except for maximal tumor size ≥3 cm for recurrence 2 years after treatment). Meanwhile, liver cirrhosis and RFA were independently associated with the increased HCC recurrence risk for almost all time points (liver cirrhosis: all p<0.05; RFA: all p<0.005 except for recurrence from 5 years after treatment). Conclusions: The recurrence rate of HCC after curative treatment gradually decreased over time. Two years after treatment, when tumor-related factors lose their prognostic implications, may be used as a cutoff to define the boundary between early and late recurrence of HCC.
Abstract
Background/Aims: We investigated changes in recurrence rates and significant recurrence predictors over time after complete cure of hepatocellular carcinoma (HCC). Methods: A total of 1,491 patients with first-time diagnosis of Barcelona Clinic Liver Cancer stage A HCC, completely cured by treatment between 2007 and 2016, were recruited from two Korean tertiary institutes. Results: The mean age of the population (1,144 men and 347 women) was 58.6 years. Of the total population, 914 patients (61.3%) had liver cirrhosis. Nine-hundred and forty-one (63.1%) and 550 (36.9%) patients were treated with surgical resection and radiofrequency ablation (RFA), respectively. One-year cumulative incidences of HCC recurrence were 14.3%, 9.9%, and 5.1% from the time of treatment, 3 years after treatment, and 5 years after treatment, respectively. Upon multivariate analysis, multiple tumors, maximal tumor size ≥3 cm, and high Model for End- Stage Liver Disease scores were independently associated with increased HCC recurrence risk from the time of treatment and 1 and 2 years after curative treatment (all p<0.05, except for maximal tumor size ≥3 cm for recurrence 2 years after treatment). Meanwhile, liver cirrhosis and RFA were independently associated with the increased HCC recurrence risk for almost all time points (liver cirrhosis: all p<0.05; RFA: all p<0.005 except for recurrence from 5 years after treatment). Conclusions: The recurrence rate of HCC after curative treatment gradually decreased over time. Two years after treatment, when tumor-related factors lose their prognostic implications, may be used as a cutoff to define the boundary between early and late recurrence of HCC.
참고문헌 (30)
- Global Burden of Disease Liver Cancer Collaboration, "The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level : results from the Global Burden of Disease Study 2015", JAMA Oncol, 3, pp.1683~1691 (2017)
- Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC, "2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma", Gut and Liver, 13(3), pp.227~299 (2019), 거트앤리버 소화기연관학회협의회[DOI]
- Colombo M, "EASL clinical practice guidelines for the management of occupational liver diseases", Liver Int, 40(Suppl 1), pp.136~141 (2020)
- Heimbach JK, "AASLD guidelines for the treatment of hepatocellular carcinoma", Hepatology, 67, pp.358~380 (2018)
- Arii S, "Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy", Cancer, 69, pp.913~919 (1992)
- Izumi R, "Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection", Gastroenterology, 106, pp.720~727 (1994)
- Koike Y, "Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesion", Hepatology, 32, pp.1216~1223 (2000)
- Lise M, "Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma : results in a series of 100 Italian patients", Cancer, 82, pp.1028~1036 (1998)
- Poon RT, "Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function : implications for a strategy of salvage transplantation", Ann Surg, 235, pp.373~382 (2002)
- Sherman M, "Recurrence of hepatocellular carcinoma", N Engl J Med, 359, pp.2045~2047 (2008)
- Llovet JM, "Resection and liver transplantation for hepatocellular carcinoma", Semin Liver Dis, 25, pp.181~200 (2005)
- Imamura H, "Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy", J Hepatol, 38, pp.200~207 (2003)
- Hoshida Y, "Risk of recurrence in hepatitis B-related hepatocellular carcinoma : impact of viral load in late recurrence", J Hepatol, 51, pp.842~844 (2009)
- Wu JC, "Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma", J Hepatol, 51, pp.890~897 (2009)
- Hirokawa F, "Risk factors and patterns of early recurrence after curative hepatectomy for hepatocellular carcinoma", Surg Oncol, 25, pp.24~29 (2016)
- Utsunomiya T, "Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma", J Gastroenterol, 45, pp.146~152 (2010)
- Cheng Z, "Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection", HPB(Oxford), 17, pp.422~427 (2015)
- Hoshida Y, "Gene expression in fixed tissues and outcome in hepatocellular carcinoma", N Engl J Med, 359, pp.1995~2004 (2008)
- Ibrahim A. Hanouneh, "Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?", Clinical and Molecular Hepatology, 25(3), pp.264~269 (2019), 대한간학회
- Lok AS, "Chronic hepatitis B", Hepatology, 45, pp.507~539 (2007)
- European Association for the Study of the Liver, "EASL clinical practice guidelines : management of chronic hepatitis B virus infection", J Hepatol, 57, pp.167~185 (2012)
- European Association for the Study of the Liver, "EASL clinical practice guidelines : management of chronic hepatitis B", J Hepatol, 50, pp.227~242 (2009)
- Korean Association for the Study of the Liver, "KASL clinical practice guidelines : management of chronic hepatitis B", Clin Mol Hepatol, 18, pp.109~162 (2012)
- Tae-Hyung Kim, "Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update", Clinical and Molecular Hepatology, 25(3), pp.245~263 (2019), 대한간학회
- Forner A, "Hepatocellular carcinoma", Lancet, 391, pp.1301~1314 (2018)
- Keun Soo Ahn, "Appropriate treatment modality for solitary small hepatocellular carcinoma: Radiofrequency ablation vs. resection vs. transplantation?", Clinical and Molecular Hepatology, 25(4), pp.354~359 (2019), 대한간학회
- Lencioni R, "Modified RECIST(mRECIST)assessment for hepatocellular carcinoma", Semin Liver Dis, 30, pp.52~60 (2010)
- Yamamoto Y, "Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy", World J Gastroenterol, 21, pp.1207~1215 (2015)
- Suk KT, "Revision and update on clinical practice guideline for liver cirrhosis", Korean J Hepatol, 18, pp.1~21 (2012)
- Kim BH, "Temporal improvement in survival of patients with hepatocellular carcinoma in a hepatitis B virus-endemic population", J Gastroenterol Hepatol, 33, pp.475~483 (2018)